Brainstorm Cell Therapeutics | BCLI - Assets


Brainstorm Cell Therapeutics reported $1.38M in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Alterity Therapeutics Limited AUD 27.32M 6.07M Jun/2023
Biogen USD 29.44B 232M Dec/2025
Brainstorm Cell Therapeutics USD 1.38M 1.19M Sep/2025
Cipla INR 401.64B 27.77B Sep/2025
Clal Biotechnology ILS 158.39M 24.3M Dec/2023
Compugen USD 97.84M 8.68M Sep/2025
CSL USD 37.9B 1.5B Dec/2025
Cytokinetics USD 1.42B 12.02M Dec/2025
Gilead Sciences USD 59.02B 490M Dec/2025
Grifols EUR 23.29B 3.35M Sep/2025
Halozyme Therapeutics USD 2.53B 304.09M Dec/2025
Mesoblast USD 782.31M 2.38M Dec/2025